Skip to main content
Premium Trial:

Request an Annual Quote

ICx Wins Mass Spec Contract for South Korea

NEW YORK (GenomeWeb News) – ICx Technologies has been awarded a multi-year contract worth up to $40 million to work with partners to develop a biological and chemical mass spectrometer for use by the South Korean military.

ICx said that its ICx Analytical Instruments business it will work jointly with ICx BioDefense to deliver a system capable of detecting both chemical and biological warfare agents that will be used in South Korean military reconnaissance vehicles.

The system will be based on the Griffin 450 mass spectrometry platform, said Dennis Barket, president of ICx Analytical Instruments, in a statement.

ICx will partner on the project with Hankuk Communication Company, located in Seoul, through Annapolis, Md.-based Tradeways, Barket said.

"Terrorism and asymmetric warfare are global problems, and we are pleased that the quality of our sensors and solutions are being recognized on an international level," ICx Technologies CEO Hans Kobler said.

ICx Technologies specializes in integrating and developing advanced sensor technologies for homeland security, force protection and commercial applications.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more